Expression of aromatase, estrogen receptors, and their coactivators in patients with endometrial cancer.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Fertility and Sterility

• Publication date

  2006-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.FERTNSTERT.2005.12.057PMID 16730717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of axin2 expression at the levels of transcription, translation and protein stability in lung and colon cancer.

  2006cited by this paper
• Aromatase and comparative response to its inhibitors in two types of endometrial cancer.

  2005cited by this paper
• Aromatase Expression in Stromal Cells of Endometrioid Endometrial Cancer Correlates with Poor Survival

  2005cited by this paper
• Is aromatase cytochrome P450 involved in the pathogenesis of endometrioid endometrial cancer?

  2005cited by this paper
• Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.

  2005cited by this paper
• Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours.

  2005cited by this paper
• Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis.

  2005cited by this paper
• Anastrozole, an aromatase inhibitor, and medroxyprogesterone acetate therapy in premenopausal obese women with endometrial cancer: a report of two cases successfully treated without hysterectomy.

  2004cited by this paper
• Local aromatase expression in human prostate is altered in malignancy.

  2004cited by this paper
• Aromatase and Endometriosis

  2004cited by this paper
• High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome.

  2004cited by this paper
• Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer

  2003cited by this paper
• Local estrogen formation by nontumoral, cirrhotic, and malignant human liver tissues and cells.

  2003cited by this paper
• Expression of estrogen receptors α and β in human lung tissue and cell lines

  2002cited by this paper
• Aromatase and its inhibitors: significance for breast cancer therapy.

  2002cited by this paper
• Liver Receptor Homologue-1 (LRH-1) Regulates Expression of Aromatase in Preadipocytes*

  2002cited by this paper
• Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects.

  2002cited by this paper
• Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion

  2002cited by this paper
• Expression of estrogen receptors alpha and beta in human lung tissue and cell lines.

  2002cited by this paper
• The postmenopausal ovary as an androgen-producing gland; hypothesis on the etiology of endometrial cancer.

  2002cited by this paper
• Aromatase--a brief overview.

  2002cited by this paper
• [Aromatase (P450AROM) mRNA expression in normal, hyperplastic and malignant endometrium and aromatase activity in endometrial cancer tissue culture].

  2000cited by this paper
• A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

  2000cited by this paper
• Analysis of Estrogen Receptor α and β in Endometrial Carcinomas: Correlation with ERβ and Clinicopathologic Findings in 45 Cases

  2000cited by this paper
• Analysis of estrogen receptor alpha and beta in endometrial carcinomas: correlation with ER beta and clinicopathologic findings in 45 cases.

  2000cited by this paper
• Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.

  2000cited by this paper
• Expression Levels of Estrogen Receptor-α, Estrogen Receptor-β, Coactivators, and Corepressors in Breast Cancer

  2000cited by this paper
• Aromatase and its inhibitors.

  1999cited by this paper
• Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis.

  1999cited by this paper
• Intratumoral aromatase in human breast, endometrial, and ovarian malignancies.

  1998cited by this paper
• Aromatase cytochrome P450 gene expression in endometrial carcinoma.

  1996cited by this paper
• Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies.

  1995cited by this paper
• Endometrial cancer. Management of high risk and recurrence including the tamoxifen controversy

  1995cited by this paper
• Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua.

  1993cited by this paper
• Immunologic identification of the aromatase enzyme system in human endometrium.

  1989cited by this paper

• Selecting Optimal Housekeeping Genes for RT-qPCR in Endometrial Cancer Studies: A Narrative Review

  2025cites this paper
• Impact of estradiol in inducing endometrial cancer using RL95-2.

  2024cites this paper
• Roles of estrogen receptor α in endometrial carcinoma (Review)

  2023cites this paper
• Reproductive disease epigenetics

  2021cites this paper
• Local estrogen metabolism (intracrinology) in endometrial cancer: A systematic review.

  2019cites this paper
• Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery

  2019influential citation
• Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells

  2018cites this paper
• Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery

  2018cites this paper
• The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers

  2017cites this paper
• Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs.

  2017cites this paper
• Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.

  2017cites this paper
• The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer

  2017cites this paper
• Steroid Sulfatase Inhibitor Reduces Proliferation of Ishikawa Endometrial Cancer Cells in Co-Culture Systems

  2016cites this paper
• Aromatase Inhibitors Beyond Breast Cancer: Endometrium Versus Breast Puzzle and Other Issues

  2015cites this paper
• Expression of estrogen receptors (α, β), cyclooxygenase-2 and aromatase in normal endometrium and endometrioid cancer of uterus.

  2013cites this paper
• The Sulfatase Pathway for Estrogen Formation: Targets for the Treatment and Diagnosis of Hormone-Associated Tumors

  2013cites this paper
• Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology

  2013cites this paper
• Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer.

  2013cites this paper
• Genetic Variants in ER Cofactor Genes and Endometrial Cancer Risk

  2012cites this paper
• Expression of ER-α36, a Novel Variant of Estrogen Receptor in Endometrial Carcinoma and Its Clinical Significance

  2012cites this paper
• Aromatase inhibition: a potential target for the management of recurrent or metastatic endometrial cancer by letrozole: more questions than answers?

  2011cites this paper
• Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.

  2009cites this paper
• Aromatase, Cyclooxygenase 2, HER-2/neu, and P53 as Prognostic Factors in Endometrioid Endometrial Cancer

  2009cites this paper
• Hormonal heterogeneity of endometrial cancer.

  2008cites this paper
• Estrogen and its receptors in cancer

  2008cites this paper
• Expression of estrogen receptors ! and " protein in endometrial carcinoma

  2008cites this paper
• COMPARATIVE ANALYSIS OF ERα AND AROMATASE GENES EXPRESSION IN TUMOROUS TISSUES OF MAMMARY GLAND AND ENDOMETRIUM

  2008cites this paper
• Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients

  2008cites this paper
• Steroid receptor coactivator 2: an essential coregulator of progestin-induced uterine and mammary morphogenesis.

  2008cites this paper
• Progesterone-action in the murine uterus and mammary gland requires steroid receptor coactivator 2: relevance to the human.

  2007cites this paper
• СРАВНИТЕЛЬНЫЙ АНАЛИЗ ЭКСПРЕССИИ ГЕНОВ ERα И АРОМАТАЗЫ В ОПУХОЛЕВЫХ ТКАНЯХ МОЛОЧНОЙ ЖЕЛЕЗЫ И ЭНДОМЕТРИЯ

  2007cites this paper
• Steroid receptor coactivator 2 is required for female fertility and mammary morphogenesis: insights from the mouse, relevance to the human

  2007cites this paper